Tag Archives: BCO

Top 5 Blue Chip Stocks To Invest In Right Now

Sports and stocks go hand in hand.

Wall Street denizens often talk about slam dunk investments and describe the economic cycle as being in a particular inning.

So it makes perfect sense that there’s an ETF dedicated to the business of sports.

The ProSports Sponsors exchange-traded fund, which has the ticker symbol FANZ (FANZ), invests in companies that have business deals with the four major US team sports leagues.

Nick Fullerton, CEO of SportsETFs, the company behind the fund, said it was set up last year to take advantage of the popularity of team sports, which bring in big dollars.

Legal gambling, which is set to spread across the United States, could boost that popularity even more.

Fullerton was quick to point out that the companies in the FANZ ETF must have an actual sponsorship with a major league, and not just a naming rights deal on a stadium.

No CMGIs or Enrons here.

“These are blue chip companies with strong balance sheets and cash flow,” Fullerton said.

Top 5 Blue Chip Stocks To Invest In Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Over the past few years, the Brink’s Company (NYSE:BCO) has defied expectations in a dinosaur industry: cash security and management. While a slew of fintech companies have risen with the almost singular purpose of ridding the world of paper currency, Brink’s has transformed itself into a multi-billion dollar cash management titan from its humble roots of transporting travelers’ valuables from train stations to hotel rooms more than a century and a half ago.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brink’s (BCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BridgeCoin (CURRENCY:BCO) traded 2.4% higher against the US dollar during the 24-hour period ending at 17:00 PM ET on May 18th. BridgeCoin has a total market capitalization of $78.45 million and approximately $39,553.00 worth of BridgeCoin was traded on exchanges in the last 24 hours. In the last week, BridgeCoin has traded up 2.2% against the US dollar. One BridgeCoin coin can now be bought for $2.91 or 0.00035182 BTC on major cryptocurrency exchanges.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Average taking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

Top 5 Blue Chip Stocks To Invest In Right Now: Fortinet, Inc.(FTNT)

Advisors’ Opinion:

  • [By Logan Wallace]

    OppenheimerFunds Inc. lessened its stake in Fortinet Inc (NASDAQ:FTNT) by 10.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,860 shares of the software maker’s stock after selling 1,023 shares during the quarter. OppenheimerFunds Inc.’s holdings in Fortinet were worth $475,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Shares of Fortinet Inc (NASDAQ:FTNT) have earned a consensus recommendation of “Buy” from the twenty-six brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $57.11.

  • [By Ethan Ryder]

    Shares of Fortinet Inc (NASDAQ:FTNT) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $61.16 and last traded at $60.96, with a volume of 30805 shares traded. The stock had previously closed at $60.35.

  • [By Chris Lange]

    Fortinet Inc.’s (NASDAQ: FTNT) short interest increased to 6.98 million shares from the previous 6.66 million. Shares were trading at $88.73. The 52-week range is $35.44 to $88.97.

Top 5 Blue Chip Stocks To Invest In Right Now: Computer Task Group, Incorporated(CTG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Computer Task Group (CTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Computer Task Group (CTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Computer Task Group (CTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Computer Task Group (NASDAQ:CTG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Computer Task Group, Incorporated provides information technology (IT) staffing, IT solutions, and application management outsourcing services in North America and Europe. The company’s staffing services consist of recruiting, retaining, and managing IT talent for its clients. Its IT solutions include helping clients assess their business needs and identifying the IT solutions for these needs, as well as the delivery of services, including the selection and implementation of packaged software, and the design, construction, testing, and integration of new systems. It serves primarily technology service providers, financial services, healthcare, and life sciences market areas.Computer Task Group was founded in 1966 by Randolph A. Marks and G. David Bae. The company is headquartered in Buffalo, New York “

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern’s scoring:

    Get Computer Task Group alerts:

    $88.05 Million in Sales Expected for Computer Task Group (CTG) This Quarter (americanbankingnews.com) CTG to Present at B. Riley Institutional Investor Conference on May 23 (finance.yahoo.com) Computer Task Group (CTG) Expected to Announce Earnings of $0.08 Per Share (americanbankingnews.com) ValuEngine Lowers Computer Task Group (CTG) to Hold (americanbankingnews.com)

    A number of brokerages recently commented on CTG. Zacks Investment Research lowered Computer Task Group from a “buy” rating to a “hold” rating in a research report on Friday, March 30th. ValuEngine lowered Computer Task Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Finally, Barrington Research reiterated a “hold” rating on shares of Computer Task Group in a research report on Friday, April 20th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $9.13.

Top 5 Blue Chip Stocks To Invest In Right Now: China Commercial Credit, Inc.(CCCR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News stories about China Commercial Credit (NASDAQ:CCCR) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. China Commercial Credit earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned news coverage about the credit services provider an impact score of 47.8379000547292 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 5 Blue Chip Stocks To Invest In Right Now: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Biopharmx Corp (NYSEAMERICAN:BPMX) were up 4.8% during mid-day trading on Tuesday . The stock traded as high as $0.22 and last traded at $0.20. Approximately 32,497 shares were traded during trading, a decline of 100% from the average daily volume of 8,266,355 shares. The stock had previously closed at $0.21.

Best Medical Stocks To Buy Right Now

Icon Plc (NASDAQ:ICLR) – Stock analysts at KeyCorp issued their Q1 2019 EPS estimates for shares of Icon in a report issued on Monday, September 10th. KeyCorp analyst D. Hooker expects that the medical research company will post earnings of $1.66 per share for the quarter. KeyCorp currently has a “Overweight” rating and a $157.00 target price on the stock. KeyCorp also issued estimates for Icon’s Q2 2019 earnings at $1.72 EPS, Q3 2019 earnings at $1.78 EPS and Q4 2019 earnings at $1.84 EPS.

Get Icon alerts:

Other equities research analysts also recently issued research reports about the company. Jefferies Financial Group lifted their target price on Icon to $150.00 and gave the stock a “buy” rating in a report on Friday, June 1st. BidaskClub upgraded Icon from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Robert W. Baird restated a “buy” rating and issued a $154.00 price objective on shares of Icon in a research report on Thursday, July 26th. SunTrust Banks boosted their price objective on Icon to $153.00 and gave the company a “buy” rating in a research report on Thursday, July 26th. Finally, Zacks Investment Research upgraded Icon from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a research report on Thursday, July 5th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $146.22.

Best Medical Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Brink’s (NYSE:BCO) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Sean Williams]

    Even though marijuana is on its way to becoming legal in Canada and it’s been given the thumbs-up for medical purposes in 30 U.S. states, this is still very much a cash business. Federal scheduling in the U.S. ensures that access to lines of credit, loans, and even a basic checking account are few and far between. Meanwhile, in Canada, only recently have banks been given the OK to work strategically with marijuana businesses. This opens the door for armored truck and ATM service companies like Brink’s Company (NYSE:BCO) to succeed.

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Average taking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

Best Medical Stocks To Buy Right Now: Noble Energy Inc.(NBL)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Noble Midstream (NYSE:NBLX) has a bold plan to grow its already impressive 7.4%-yielding distribution to investors by 20% per year all the way through 2022, which is one of the fastest rates in the midstream sector. Driving that growth would be the expansion of the company’s oil and gas gathering system to support the anticipated increase in production from customers like its parent, Noble Energy (NYSE:NBL).

  • [By Matthew DiLallo]

    Fueling that forecast is the company’s ability to expand its midstream footprint to support the growth of its customers, including its parent Noble Energy (NYSE:NBL). The company operates several gathering systems in both the Permian Basin and DJ Basin that it expects to continue expanding as customers drill more wells.

  • [By Dan Caplinger]

    Yet along with those gains has come continued volatility, and even among the biggest companies in the market, some have faced substantial setbacks that have caused their shares to fall 15% or more in August. As of today, Hanesbrands (NYSE:HBI), Dentsply Sirona (NASDAQ:XRAY), and Noble Energy (NYSE:NBL) have been the worst-performing members of the S&P 500 so far this month, and below, you’ll learn more about how they got there and what’s ahead for their respective businesses.

Best Medical Stocks To Buy Right Now: Materialise NV(MTLS)

Advisors’ Opinion:

  • [By Logan Wallace]

    TheStreet upgraded shares of Materialise (NASDAQ:MTLS) from a c+ rating to a b- rating in a research report report published on Thursday.

    Several other brokerages have also commented on MTLS. BidaskClub upgraded shares of Materialise from a sell rating to a hold rating in a report on Tuesday, August 28th. ValuEngine upgraded shares of Materialise from a hold rating to a buy rating in a report on Friday, August 24th. Finally, Zacks Investment Research lowered shares of Materialise from a hold rating to a strong sell rating in a report on Thursday, August 9th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of $19.00.

  • [By Joseph Griffin]

    Blackline (NASDAQ: MTLS) and Materialise (NASDAQ:MTLS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Navigator (NYSE:NVGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Royal Caribbean Cruises (NYSE:RCL) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: First Busey Corporation(BUSE)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of First Busey Co. (NASDAQ:BUSE) hit a new 52-week high and low during trading on Monday . The company traded as low as $33.22 and last traded at $32.70, with a volume of 1006 shares traded. The stock had previously closed at $33.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In other news, after a week, shares of T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) are lower than they were before they announced a merger deal. The Fools discuss the likelihood of the plan making it past regulators and shareholders to closing, and consider whether it would be a win or a loss for customers.

  • [By ]

    Of course T-Mobile (TMUS) and Sprint (S) have reportedly restarted merger talks, joining forces to take on Verizon (VZ) and AT&T (T) makes perfect sense.

  • [By Adam Levy]

    T-Mobile (NASDAQ:TMUS) has been looking to get into video distribution since its Layer3 TV acquisition in December 2017. The company initially planned to launch a pay-TV service by the end of 2018, but it’s pushed back those plans to the first half of 2019.

  • [By ]

    After years of on-again, off-again talks, Sprint (S) and T-Mobile (TMUS)  finally announced a merger Sunday.

    Sprint investors will receive 0.10256 shares of T-Mobile for each share of Sprint. Based on T-Mobile’s close at $64.52 on Friday, the deal values Sprint at $6.62 per share. Including assumed debt, the deal values Sprint at about $59 billion.

Top Blue Chip Stocks To Buy Right Now

U.K. stocks on Wednesday wavered, with the International Monetary Fund set to offer its assessment of the British economy, but blue chips remained close to a six-week high.

London-listed shares were lower alongside other global markets, which were unable to gain much traction after U.S. lawmakers made a major push forward into overhauling the country’s tax code.

How markets are moving: The FTSE 100 index
UKX, -0.13%
was up 1 point at 7,545.46 after dipping into negative territory. The basic materials and health care groups were gaining the most, but consumer goods and utilities were among the sector that fell. On Tuesday, the index rose 0.1% and marked it best close since Nov. 6.

Top Blue Chip Stocks To Buy Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Arrow Electronics (ARW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Arrow Electronics (NYSE:ARW) Q4 2018 Earnings Conference CallFeb. 7, 2019 1:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lee Jackson]

    This award-winning company looks poised to come in strong for the quarter. Arrow Electronics Inc. (NYSE: ARW) is a worldwide provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions.

  • [By Ethan Ryder]

    PNC Financial Services Group Inc. increased its holdings in Arrow Electronics, Inc. (NYSE:ARW) by 29.7% in the first quarter, HoldingsChannel.com reports. The firm owned 19,225 shares of the technology company’s stock after buying an additional 4,405 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Arrow Electronics were worth $1,480,000 at the end of the most recent reporting period.

Top Blue Chip Stocks To Buy Right Now: Kitov Pharamceuticals Holdings Ltd.(KTOV)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 17 percent to $2.53. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: AMBO) were down 26 percent to $4.1999.

  • [By Lisa Levin]

    Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 16 percent to $2.56. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.

    Shares of Ambow Education Holding Ltd. (NASDAQ: GLNG) were down 28 percent to $4.10.

Top Blue Chip Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brink’s (BCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Blue Chip Stocks To Buy Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Jim Crumly]

    As for individual stocks, Boeing (NYSE:BA) slumped due to trade concerns, and Sarepta Therapeutics (NASDAQ:SRPT) soared following positive trial results.

  • [By Todd Campbell]

    Investors cheered news that PTC Therapeutics’ (NASDAQ:PTCT) clinical-stage drug for spinal muscular atrophy (SMA) is delivering impressive early-stage efficacy. However, those cheers turned to jeers after competitor Sarepta Therapeutics (NASDAQ:SRPT) reported promising data for its Duchenne muscular dystrophy (DMD) gene therapy. Could Sarepta Therapeutics’ next-generation DMD treatment derail sales of PTC Therapeutics’ existing DMD drugs? And how excited should investors be about PTC Therapeutics’ opportunity to reshape SMA treatment anyway?

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’re smart picks to buy now.

  • [By Keith Speights]

    Three gene therapy stocks aren’t just hot in 2018 — they’re red-hot. Shares of  Sarepta Therapeutics (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), and uniQure (NASDAQ:QURE) have nearly doubled or generated even greater gains so far this year. But is it too late for investors to buy these gene therapy stocks? Here’s what you need to know.

  • [By Max Byerly]

    Royal Bank of Canada restated their outperform rating on shares of Sarepta Therapeutics (NASDAQ:SRPT) in a research report report published on Wednesday morning, MarketBeat reports. The firm currently has a $200.00 target price on the biotechnology company’s stock, up from their previous target price of $187.00.

Top Medical Stocks To Watch Right Now

A Super Bowl commercial aimed at people suffering from opioid-induced constipation has incited public outrage. A Super Bowl ad for opioid-induced constipation has sparked a major backlash.

The ad, which reached more than 111 million viewers, touted a drug to help opioid users suffering from irregularity. But many medical and political leaders saw it as an attempt to capitalize on the opioid epidemic that’s plaguing the country.

“It’s very disturbing to see an ad like that,” said Dr. Andrew Kolodny, executive director of Physicians for Responsible Opioid Prescribing. “It’s normalizing the chronic use of opioids, which aren’t demonstrated to be safe over the long term.”

“Opioids block pain signals but can also block activity in the bowel,” said the ad, which was presented by AstraZeneca and Daiichi Sankyo. Together, they sell the drug Movantik, which treats opioid-induced constipation. Neither company produces opioids.

Top Medical Stocks To Watch Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Logan Wallace]

    BridgeCoin (CURRENCY:BCO) traded 2.4% higher against the US dollar during the 24-hour period ending at 17:00 PM ET on May 18th. BridgeCoin has a total market capitalization of $78.45 million and approximately $39,553.00 worth of BridgeCoin was traded on exchanges in the last 24 hours. In the last week, BridgeCoin has traded up 2.2% against the US dollar. One BridgeCoin coin can now be bought for $2.91 or 0.00035182 BTC on major cryptocurrency exchanges.

  • [By Max Byerly]

    Wells Fargo & Company MN lessened its stake in shares of Brink’s (NYSE:BCO) by 9.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,216,995 shares of the business services provider’s stock after selling 119,750 shares during the period. Wells Fargo & Company MN’s holdings in Brink’s were worth $86,833,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Brink’s (NYSE:BCO) shares shot up 16.2% on Thursday after Buckingham Research raised their price target on the stock from $5.14 to $110.00. Buckingham Research currently has a buy rating on the stock. Brink’s traded as high as $82.45 and last traded at $79.25. 2,991,171 shares changed hands during trading, an increase of 539% from the average session volume of 467,825 shares. The stock had previously closed at $68.20.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Averagetaking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

Top Medical Stocks To Watch Right Now: Loral Space and Communications Inc.(LORL)

Advisors’ Opinion:

  • [By Max Byerly]

    Loral Space & Communications (NASDAQ:LORL) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Stephan Byrd]

    Loral Space & Communications Ltd. (NASDAQ: LORL) and Maxar Technologies (NYSE:MAXR) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Stephan Byrd]

    Loral Space & Communications Ltd. (NASDAQ:LORL) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Tuesday.

Top Medical Stocks To Watch Right Now: Stamps.com Inc.(STMP)

Advisors’ Opinion:

  • [By Max Byerly]

    Stamps.com (NASDAQ: STMP) and Total System Services (NYSE:TSS) are both retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings.

  • [By Demitrios Kalogeropoulos]

    Stamps.com (NASDAQ:STMP) has outgrown the market through the first six months of 2018 by rising 35% compared to a 2% uptick in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Timothy Green]

    Shares of Stamps.com (NASDAQ:STMP) slumped on Thursday after the Trump administration proposed a federal government reorganization, including an overhaul and potential privatization of the U.S. Postal Service. The stock was down 10.2% when the market closed.

Top Medical Stocks To Watch Right Now: MMA Capital Management, LLC(MMAC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Municipal Mortgage & Equity, LLC (NASDAQ:MMAC) EVP Gary A. Mentesana purchased 500 shares of the stock in a transaction dated Tuesday, May 15th. The shares were acquired at an average price of $28.44 per share, with a total value of $14,220.00. Following the transaction, the executive vice president now owns 171,641 shares in the company, valued at $4,881,470.04. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Top Medical Stocks To Watch Right Now: POSCO(PKX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Mount Yale Investment Advisors LLC acquired a new position in POSCO (NYSE:PKX) during the first quarter, according to its most recent filing with the SEC. The firm acquired 2,035 shares of the basic materials company’s stock, valued at approximately $160,000.

  • [By Max Byerly]

    Media coverage about POSCO (NYSE:PKX) has trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. POSCO earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave news headlines about the basic materials company an impact score of 46.5366586800129 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top Medical Stocks To Watch Right Now: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Cytokinetics (CYTK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cytokinetics (CYTK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cytokinetics (NASDAQ:CYTK) had its price target cut by investment analysts at Piper Jaffray Companies to $13.00 in a note issued to investors on Monday. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Piper Jaffray Companies’ price objective would indicate a potential upside of 55.69% from the stock’s previous close.

Top 5 Low Price Stocks To Buy Right Now

Photographer: Saul Martinez/Bloomberg

A strategic mistake made six years ago by celebrity CEO Ron Johnson continues to haunt popular retailer JC Penney, as evidenced by the ongoing sluggish sales growth and store closings that have made the company smaller—a fraction of what it once  was.

Meanwhile, investors have been bailing out from the company’s stock, which trades in the middle single digits — a long way from the upper 30s, where it was trading back in 2012. 

JC Penney’s woes began with a change in the retailer’s pricing strategy –replacement of coupon sales with everyday low prices.

The old pricing strategy has been popular among retailers, because it hypes shoppers, making them feel smart and encouraging them to talk with other consumers about it. That’s how hype and buzz for merchandise begins and spreads in the shopper community.

Top 5 Low Price Stocks To Buy Right Now: Airgas Inc.(ARG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Argentum (CURRENCY:ARG) traded 3.6% lower against the US dollar during the one day period ending at 19:00 PM ET on May 27th. In the last week, Argentum has traded 2.8% lower against the US dollar. Argentum has a total market capitalization of $1.66 million and approximately $610.00 worth of Argentum was traded on exchanges in the last day. One Argentum coin can currently be purchased for about $0.17 or 0.00002374 BTC on popular cryptocurrency exchanges including Cryptopia and CoinExchange.

Top 5 Low Price Stocks To Buy Right Now: Gogo Inc.(GOGO)

Advisors’ Opinion:

  • [By Paul Ausick]

    Gogo Inc. (NASDAQ: GOGO) traded down more than 34% Tuesday to post a new 52-week low of $5.46 after closing Monday at $8.33. The stock’s 52-week high is $14.76. Volume was about 10 times the daily average of around 1.1 million shares. The in-flight WiFi provider had its credit rating downgraded and its outlook cut to negative this morning.

  • [By ]

    Gogo Inc (Nasdaq: GOGO) reported record quarterly results in February with revenue up 18% over last year’s fourth quarter. The company missed high expectations for earnings, sending shares tumbling towards a 52-week low. Short sellers have piled on selling 53% of shares available and pushing the cover ratio up to 16 days.

  • [By Logan Wallace]

    Gogo (NASDAQ:GOGO) was upgraded by investment analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Max Byerly]

    Gogo (NASDAQ:GOGO) last issued its earnings results on Friday, May 4th. The technology company reported ($0.34) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.58) by $0.24. The firm had revenue of $231.83 million during the quarter, compared to analyst estimates of $221.48 million. The firm’s revenue was up 40.2% compared to the same quarter last year. During the same period last year, the business earned ($0.52) EPS. analysts predict that Gogo Inc will post -2.21 earnings per share for the current fiscal year.

  • [By Dan Caplinger]

    The stock market dealt with continued volatility on Tuesday, with investors uncertain how to react to a mix of earnings and geopolitical news. Throughout most of the day, market participants were trying to predict whether the Trump administration would move forward with its plans to withdraw the U.S. from the nuclear deal with Iran, and major benchmarks stayed in a relatively tight range with a downward bias during the morning and early afternoon. After the expected announcement, the Dow fell to a triple-digit loss late in the afternoon, but it recovered by the end of the session. Adding to the gloominess was bad news regarding some key individual stocks. DISH Network (NASDAQ:DISH), Gogo (NASDAQ:GOGO), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

Top 5 Low Price Stocks To Buy Right Now: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Investors in satellite telecom Iridium Communications (NASDAQ:IRDM) reacted positively after the company reported good results to kick off 2018. Iridium’s new satellite constellation is nearing completion, but the company is already reaping benefits.

  • [By Max Byerly]

    Iridium Communications (NASDAQ: IRDM) and Inseego (NASDAQ:INSG) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

  • [By Max Byerly]

    Prudential Financial Inc. decreased its holdings in shares of Iridium Communications Inc (NASDAQ:IRDM) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,187,699 shares of the technology company’s stock after selling 75,910 shares during the period. Prudential Financial Inc. owned approximately 1.08% of Iridium Communications worth $13,361,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Iridium Communications (NASDAQ:IRDM) last announced its earnings results on Thursday, April 26th. The technology company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. The business had revenue of $119.10 million during the quarter, compared to the consensus estimate of $111.60 million. Iridium Communications had a net margin of 44.81% and a return on equity of 5.19%. Iridium Communications’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.30 EPS. sell-side analysts forecast that Iridium Communications Inc will post 0.11 EPS for the current year.

  • [By Stephen Mack]

    Iridium Communications Inc. (Nasdaq: IRDM) provides communication where land-based services won’t do. This includes communications for construction and utilities applications, or among aviation fleets for commercial and government purposes. It includes maritime applications, from fishing and merchant shipping to research vessels. And it includes communications for the U.S. Department of Defense, ranging from emergency communications in the field to keeping soldiers in touch with people back home.

Top 5 Low Price Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Max Byerly]

    BridgeCoin (CURRENCY:BCO) traded 8.5% lower against the dollar during the 1 day period ending at 15:00 PM ET on July 1st. BridgeCoin has a market cap of $29.27 million and approximately $9,187.00 worth of BridgeCoin was traded on exchanges in the last 24 hours. One BridgeCoin coin can currently be bought for $1.08 or 0.00017157 BTC on popular cryptocurrency exchanges. Over the last week, BridgeCoin has traded 34.1% higher against the dollar.

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Brink’s (NYSE:BCO) shares shot up 16.2% on Thursday after Buckingham Research raised their price target on the stock from $5.14 to $110.00. Buckingham Research currently has a buy rating on the stock. Brink’s traded as high as $82.45 and last traded at $79.25. 2,991,171 shares changed hands during trading, an increase of 539% from the average session volume of 467,825 shares. The stock had previously closed at $68.20.

Top 5 Low Price Stocks To Buy Right Now: Seaboard Corporation(SEB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Willis Investment Counsel lifted its holdings in Seaboard Co. (NYSEAMERICAN:SEB) by 8.5% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 524 shares of the company’s stock after acquiring an additional 41 shares during the period. Willis Investment Counsel’s holdings in Seaboard were worth $2,235,000 as of its most recent filing with the SEC.